USE OF AN INHIBITOR OF TNFA PLUS AN ANTIHISTAMINE TO TREAT ALLERGIC RHINITIS AND ALLERGIC CONJUNCTIVITIS

• 1. TNFα抑制剂联合抗组胺药治疗变应性鼻炎和变应性结膜炎的用途 [P] . 中国专利： CN101641094A . 2010-02-03
• 2. 一种治疗过敏性结膜炎和/或过敏性鼻炎的中药组合物 [P] . 中国专利： CN113786452A . 2021-12-14
• 3. USE OF AN INHIBITOR OF TNFA PLUS AN ANTIHISTAMINE TO TREAT ALLERGIC RHINITIS AND ALLERGIC CONJUNCTIVITIS [P] . 欧洲知识产权局专利： EP2131834A2 . 2009-12-16

  机译： 使用TNFA抑制剂和抗组胺药治疗过敏性鼻炎和过敏性结膜

• 4. USE OF AN INHIBITOR OF TNFA PLUS AN ANTIHISTAMINE TO TREAT ALLERGIC RHINITIS AND ALLERGIC CONJUNCTIVITIS [P] . 世界知识产权组织专利： WO2008127975A3 . 2009-07-30

  机译： 使用TNFA抑制剂和抗组胺药治疗过敏性鼻炎和过敏性结膜

• 5. USE OF AN INHIBITOR OF TNFA PLUS AN ANTIHISTAMINE TO TREAT ALLERGIC RHINITIS AND ALLERGIC CONJUNCTIVITIS. [P] . MX2009010946A . 2009-10-29

  机译： 使用TNFA抑制剂和抗组胺药治疗过敏性鼻炎和过敏性结膜。

• 1. Pediatric allergic conjunctivitis and allergic rhinitis [J] . Tong Qiao, Yizhen Hu, Zhinan Wang 生物医学研究杂志（英文版） . 2008,第003期
• 2. Systematic review and Meta-analysis of Peitu Shengjin prescription versus H1 antihistamine in the treatment of allergic rhinitis [J] . Wen-Feng He, Dong-Xu Si, Yue Yan, 海南医科大学学报（英文版） . 2021,第015期
• 3. Systematic review and Meta-analysis of Peitu Shengjin prescription versus H1 antihistamine in the treatment of allergic rhinitis [J] . Wen-Feng He, Dong-Xu Si, Yue Yan, 海南医科大学学报(英文版) . 2021,第015期
• 4. Mahuang Xixin Fuzi decoction protects against ovalbumin-induced allergic rhinitis by inhibiting type 2 innate lymphoid cells in mice [J] . Hong Ren, Wenting Ji, Xue Yu, 中医科学杂志（英文） . 2019,第004期
• 5. Mahuang Xixin Fuzi decoction protects against ovalbumin-induced allergic rhinitis by inhibiting type 2 innate lymphoid cells in mice [J] . Hong Ren, Wenting Ji, Xue Yu, 中医科学杂志(英文) . 2019,第004期
• 6. Topical Antihistamines and Mast Cell Stabilizers for Treating Allergic Conjunctivitis [J] . Mounsey Anne L., Gray Richard E. American Family Physician . 2016,第11期
• 7. Combination treatment for allergic conjunctivitis - Plant derived histidine decarboxylase inhibitor and H1 antihistaminic drug [J] . Bakrania Anita K., Patel Snehal S. Experimental Eye Research . 2015,第Null期
• 8. CSACI position statement: Newer generation H 1 -antihistamines are safer than first-generation H 1 -antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria [J] . Michael N. Fein, David A. Fischer, Andrew W. O’Keefe, Allergy, Asthma & Clinical Immunology . 2019,第1期
• 9. A BIOMIMETIC APPROACH OF RECOGNITIVE CONTACT LENSES FOR TAILORED LOADING AND RELEASE OF ANTIHISTAMINES TO TREAT ALLERGIC RHINOCONJUNCTIVITIS [C] . S. Venkatesh, S.P. Sizemore, J.B. Zhang, Society for Biomaterials Transaction Annual Meeting vol.29 pt.1 . 2006
• 10. The impact of nasal congestion and rural residence on pulmonary function and asthma control in adults with asthma and allergic rhinitis. [D] . Hogan, Donna Grace. 2011
• 11. Rhinitis Treatment 1: 148 Levels of F VCAM and ICAM in Patients With Allergic Rhino-Conjunctivitis and H1 Antihistamines [O] . Ioana Adriana Bujor, Bocsan Ioana Corina, Diana Deleanu 2012
• 12. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis [O] . Castillo, M, Scott, N W, Mustafa, M Z, 2015

• 1. 过敏性结膜炎的中医药治疗 [C] . 李欣 ,庄曾渊 . 中华中医药学会眼科分会第十六次学术年会、世界中医药学会联合会眼科专业委员会第七次学术年会、中国医师协会中西医结合医师分会眼科专业委员会第二次学术会议、北京中西医结合学会第五届眼科专业委员会第三次学术年会、第三次京津冀中西医结合眼科学术交流会 . 2017
• 2. 三种第二代抗组胺药治疗过敏性鼻炎和荨麻疹有效性和安全性评价 [A] . 秦雯霞 . 2007